C4 Therapeutics
CCCC
CCCC
101 hedge funds and large institutions have $78.2M invested in C4 Therapeutics in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
13.24% less ownership
Funds ownership: 90.3% → 77.06% (-13%)
24% less capital invested
Capital invested by funds: $103M → $78.2M (-$24.3M)
33% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 39
Holders
101
Holding in Top 10
1
Calls
$111K
Puts
$14K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$1.26M | |
| 3 | +$1.01M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1M |
| 5 |
Jane Street
New York
|
+$686K |
Top Sellers
| 1 | -$4.94M | |
| 2 | -$4.82M | |
| 3 | -$1.93M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.55M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.41M |
